Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 4/2017

Content (10 Articles)

New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?

  • Current Opinion

Michael Berry, Brijesh V. Patel, Stephen J. Brett

Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview

  • Review Article

Pieter Hindryckx, Gregor Novak, Niels Vande Casteele, Reena Khanna, Debby Laukens, Jairath Vipul, Brian G. Feagan

Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview

  • Erratum

Pieter Hindryckx, Gregor Novak, Niels Vande Casteele, Reena Khanna, Debby Laukens, Vipul Jairath, Brian G. Feagan

Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression

  • Review Article

Marc S. Lener, Bashkim Kadriu, Carlos A. Zarate Jr

Abuse and Misuse of Pregabalin and Gabapentin

  • Systematic Review

Kirk E. Evoy, Megan D. Morrison, Stephen R. Saklad

Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence

  • Original Research Article

Joshua J. Gagne, Jennifer M. Polinski, Wenlei Jiang, Sarah K. Dutcher, Jing Xie, Joyce Lii, Lisa A. Fulchino, Aaron S. Kesselheim

Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma

  • Adis Drug Evaluation

Lesley J. Scott

Daclizumab: A Review in Relapsing Multiple Sclerosis

  • Adis Drug Evaluation

Matt Shirley

Apremilast: A Review in Psoriasis and Psoriatic Arthritis

  • Adis Drug Evaluation

Gillian M. Keating

Nusinersen: First Global Approval

  • AdisInsight Report

Sheridan M. Hoy

Mar 17
Issue: 3/2017
Apr 17
Issue: 5/2017

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images